Fundraising Fox
Hemocorp
Singapore, SG · 1 known investors
Find your way into Hemocorp
Sign up to see every warm intro you have to Hemocorp
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hemocorp team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Hemo Group develops interventional medical devices for treating neuro-vascular diseases, including ischemic stroke, hemorrhagic stroke, and neuro access, with products such as the Afentta intracranial thrombectomy device. The company markets its devices across Europe, Asia, and the Middle East, with R&D conducted in the US.
Investors · 1
Frequently asked questions
- What does Hemocorp do?
- Hemo Group develops interventional medical devices for treating neuro-vascular diseases, including ischemic stroke, hemorrhagic stroke, and neuro access, with products such as the Afentta intracranial thrombectomy device. The company markets its devices across Europe, Asia, and the Middle East, with R&D conducted in the US.
- Who are Hemocorp's investors?
- Hemocorp's investors include Delos Capital.
- Where is Hemocorp headquartered?
- Hemocorp is headquartered in Singapore, SG.